Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 200-211

  Whitaker, Paul ^a   Meng, Xiaoli ^b,c   Lavergne, Sidonie N ^b,d   El Ghaiesh, Sabah ^b,e   Monshi, Manal ^b,f   Earnshaw, Caroline ^b   Peckham, Daniel ^a   Gooi, Jimmy ^a   Conway, Steve ^a   Pirmohamed, Munir ^b,c   Jenkins, Rosalind E ^b   Naisbitt, Dean J ^b   Park, B Kevin ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c and University of Bristol   (United Kingdom)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e TANTA UNIVERSITY   (Egypt)

^f KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIGEN; CYTOKINE; EPITOPE; GRANZYME B; HAPTEN; LYSINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANGIONEUROTIC EDEMA; ANTIGEN DETECTION; ANTIGENICITY; ARTHRALGIA; ARTICLE; CHEST TIGHTNESS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ENZYME RELEASE; EOSINOPHILIA; EX VIVO STUDY; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MACULOPAPULAR RASH; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PRURITUS; T LYMPHOCYTE ACTIVATION; URTICARIA;

AMINO ACID SEQUENCE; ANTIGENS; CELL LINE; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; CLONE CELLS; CYSTIC FIBROSIS; DRUG HYPERSENSITIVITY; FEMALE; HAPTENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PIPERACILLIN; PROTEIN BINDING; SERUM ALBUMIN; SKIN TESTS; T-LYMPHOCYTES; TANDEM MASS SPECTROMETRY;

EID: 79960427633     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100647     Document Type: Article

References (46)

1. Beeler, A., O. Engler, B. O. Gerber, and W. J. Pichler. 2006. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J. Allergy Clin. Immunol. 117: 455-462.
2. Brander, C., D. Mauri-Hellweg, F. Bettens, H. Rolli, M. Goldman, and W. J. Pichler. 1995. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J. Immunol. 155: 2670-2678.
3. Castrejon, J. L., N. Berry, S. El-Ghaiesh, B. Gerber, W. J. Pichler, B. K. Park, and D. J. Naisbitt. 2010. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J. Allergy Clin. Immunol. 125: 411-418.e4.
4. Nassif, A., A. Bensussan, L. Boumsell, A. Deniaud, H. Moslehi, P. Wolkenstein, M. Bagot, and J. C. Roujeau. 2004. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J. Allergy Clin. Immunol. 114: 1209-1215.
5. Schnyder, B., C. Burkhart, K. Schnyder-Frutig, S. von Greyerz, D. J. Naisbitt, M. Pirmohamed, B. K. Park, and W. J. Pichler. 2000. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J. Immunol. 164: 6647-6654.
6. Wu, Y., J. Farrell, M. Pirmohamed, B. K. Park, and D. J. Naisbitt. 2007. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J. Allergy Clin. Immunol. 119: 973-981.
7. Elsheikh, A., S. N. Lavergne, J. L. Castrejon, J. Farrell, H. Wang, J. Sathish, W. J. Pichler, B. K. Park, and D. J. Naisbitt. 2010. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. J. Immunol. 185: 6448-6460.
8. Padovan, E., T. Bauer, M. M. Tongio, H. Kalbacher, and H. U. Weltzien. 1997. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur. J. Immunol. 27: 1303-1307.
9. Padovan, E., D. Mauri-Hellweg, W. J. Pichler, and H. U. Weltzien. 1996. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur. J. Immunol. 26: 42-48.
10. Burkhart, C., S. von Greyerz, J. P. Depta, D. J. Naisbitt, M. Britschgi, K. B. Park, and W. J. Pichler. 2001. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole- metabolite-specific human CD4+ T-cells. Br. J. Pharmacol. 132: 623-630.
11. Depta, J. P., F. Altznauer, K. Gamerdinger, C. Burkhart, H. U. Weltzien, and W. J. Pichler. 2004. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. J. Allergy Clin. Immunol. 113: 519-527.
12. Farrell, J., D. J. Naisbitt, N. S. Drummond, J. P. Depta, F. J. Vilar, M. Pirmohamed, and B. K. Park. 2003. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J. Pharmacol. Exp. Ther. 306: 229-237.
13. Hashizume, H., M. Takigawa, and Y. Tokura. 2002. Characterization of drugspecific T cells in phenobarbital-induced eruption. J. Immunol. 168: 5359-5368. (Pubitemid 34496005)
14. Keller, M., M. Lerch, M. Britschgi, V. Tâche, B. O. Gerber, M. Lüthi, P. Lochmatter, G. Kanny, A. J. Bircher, C. Christiansen, and W. J. Pichler. 2010. Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells. Clin. Exp. Allergy 40: 257-268.
15. Naisbitt, D. J., J. Farrell, G. Wong, J. P. Depta, C. C. Dodd, J. E. Hopkins, C. A. Gibney, D. W. Chadwick, W. J. Pichler, M. Pirmohamed, and B. K. Park. 2003. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J. Allergy Clin. Immunol. 111: 1393-1403.
16. Schnyder, B., D. Mauri-Hellweg, M. Zanni, F. Bettens, and W. J. Pichler. 1997. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J. Clin. Invest. 100: 136-141.
17. Batchelor, F. R., J. M. Dewdney, and D. Gazzard. 1965. Penicillin allergy: the formation of the penicilloyl determinant. Nature 206: 362-364.
18. Levine, B. B. 1960. Studies on the mechanism of the formation of the penicillin antigen. I. Delayed allergic cross-reactions among penicillin G and its degradation products. J. Exp. Med. 112: 1131-1156.
19. Levine, B. B., and Z. Ovary. 1961. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J. Exp. Med. 114: 875-904.
20. Callan, H. E., R. E. Jenkins, J. L. Maggs, S. N. Lavergne, S. E. Clarke, D. J. Naisbitt, and B. K. Park. 2009. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation. Chem. Res. Toxicol. 22: 937-948.
21. Jenkins, R. E., X. Meng, V. L. Elliott, N. R. Kitteringham, M. Pirmohamed, and B. K. Park. 2009. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin. Appl. 3: 720-729.
22. Jenkinson, C., R. E. Jenkins, M. Aleksic, M. Pirmohamed, D. J. Naisbitt, and B. K. Park. 2010. Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein. J. Invest. Dermatol. 130: 732-742.
23. Jenkinson, C., R. E. Jenkins, J. L. Maggs, N. R. Kitteringham, M. Aleksic, B. K. Park, and D. J. Naisbitt. 2009. A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine. Chem. Res. Toxicol. 22: 1172-1180.
24. Burrows, J. A., L. M. Nissen, C. M. Kirkpatrick, and S. C. Bell. 2007. Betalactam allergy in adults with cystic fibrosis. J. Cyst. Fibros. 6: 297-303.
25. Koch, C., K. Hjelt, S. S. Pedersen, E. T. Jensen, T. Jensen, S. Lanng, N. H. Valerius, M. Pedersen, and N. Høiby. 1991. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Rev. Infect. Dis. 13 (Suppl 7): S608-S611.
26. Pleasants, R. A., T. R. Walker, and W. M. Samuelson. 1994. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest 106: 1124-1128.
27. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
28. Torres, M. J., M. Blanca, J. Fernandez, A. Romano, A. Weck, W. Aberer, K. Brockow, W. J. Pichler, and P. Demoly; ENDA; EAACI Interest Group on Drug Hypersensitivity. 2003. Diagnosis of immediate allergic reactions to betalactam antibiotics. Allergy 58: 961-972.
29. Ghibellini, G., A. S. Bridges, C. N. Generaux, and K. L. Brouwer. 2007. In vitro and in vivo determination of piperacillin metabolism in humans. Drug Metab. Dispos. 35: 345-349.
30. Landsteiner, K., and J. Jacobs. 1935. Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 61: 643-656.
31. Lavergne, S. N., B. K. Park, and D. J. Naisbitt. 2008. The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 8: 299-307.
32. Park, B. K., M. Pirmohamed, and N. R. Kitteringham. 1998. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 11: 969-988.
33. Hayashi, Y., J. A. Roberts, D. L. Paterson, and J. Lipman. 2010. Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opin. Drug Metab. Toxicol. 6: 1017-1031.
34. Anderson, N. L., and N. G. Anderson. 2002. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1: 845-867.
35. Müller, N., B. Schneider, K. Pfizenmaier, and H. Wajant. 2010. Superior serum half life of albumin tagged TNF ligands. Biochem. Biophys. Res. Commun. 396: 793-799.
36. Fasano, M., S. Curry, E. Terreno, M. Galliano, G. Fanali, P. Narciso, S. Notari, and P. Ascenzi. 2005. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57: 787-796. (Pubitemid 43062399)
37. Sudlow, G., D. J. Birkett, and D. N. Wade. 1975. Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol. Clin. Exp. Pharmacol. Physiol. 2: 129-140.
38. Hertl, M., H. Bohlen, F. Jugert, C. Boecker, R. Knaup, and H. F. Merk. 1993a. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics. J. Invest. Dermatol. 101: 794-799.
39. Hertl, M., J. Geisel, C. Boecker, and H. F. Merk. 1993b. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br. J. Dermatol. 128: 619-626.
40. Lochmatter, P., A. Beeler, T. T. Kawabata, B. O. Gerber, and W. J. Pichler. 2009. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. Allergy 64: 1269-1278.
41. Rozieres, A., A. Hennino, K. Rodet, M. C. Gutowski, N. Gunera-Saad, F. Berard, G. Cozon, J. Bienvenu, and J. F. Nicolas. 2009. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64: 534-542.
42. Yawalkar, N., Y. Hari, K. Frutig, F. Egli, T. Wendland, L. R. Braathen, and W. J. Pichler. 2000. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J. Invest. Dermatol. 115: 647-652.
43. Pichler, W. J., M. Zanni, S. von Greyerz, B. Schnyder, D. Mauri-Hellweg, and T. Wendland. 1997. High IL-5 production by human drug-specific T cell clones. Int. Arch. Allergy Immunol. 113: 177-180.
44. Yawalkar, N., M. Shrikhande, Y. Hari, H. Nievergelt, L. R. Braathen, and W. J. Pichler. 2000b. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J. Allergy Clin. Immunol. 106: 1171-1176.
45. Lima, C. M., J. T. Schroeder, C. E. Galvão, F. M. Castro, J. Kalil, and N. F. Adkinson Jr. 2010. Functional changes of dendritic cells in hypersensivity reactions to amoxicillin. Braz. J. Med. Biol. Res. 43: 964-968.
46. Rodriguez-Pena, R., S. Lopez, C. Mayorga, C. Antunez, T. D. Fernandez, M. J. Torres, and M. Blanca. 2006. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J. Allergy Clin. Immunol. 118: 949-956.